Patent: 10,220,076
✉ Email this page to a colleague
Summary for Patent: 10,220,076
| Title: | Pharmaceutical compositions and methods for fabrication of solid masses comprising glucose regulating proteins |
| Abstract: | Embodiments of the invention provide shaped masses comprising one or more drugs such as proteins or polypeptides and methods for forming such shaped masses. One embodiment provides a shaped mass comprising a drug such as a protein or polypeptide having a biological activity in the body of a mammal. The shaped mass is formed by compression of a precursor material comprising the drug wherein an amount of biologically active drug in the mass is a preserved above a minimum level. Drugs which may be incorporated into the shaped mass may include one or more glucose regulating proteins such as insulin, incretins; and immunoglobulins such as TNF-inhibiting antibodies or interleukin neutralizing antibodies. Embodiments of the shaped mass may be incorporated into a tissue penetrating member which is inserted into the intestinal wall allowing for the oral delivery of proteins and peptides which would otherwise be degraded in the intestinal tract. |
| Inventor(s): | Morales; Mercedes (San Jose, CA), Imran; Mir (Los Altos Hills, CA), Korupolu; Radhika (San Jose, CA), Hashim; Mir (Fremont, CA) |
| Assignee: | InCube Labs, LLC (San Jose, CA) |
| Application Number: | 14/714,146 |
| Patent Claims: | see list of patent claims |
Details for Patent 10,220,076
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Eli Lilly And Company | HUMULIN R U-100 | insulin human | Injection | 018780 | October 28, 1982 | ⤷ Subscribe | 2034-05-15 |
| Eli Lilly And Company | HUMULIN R U-500 | insulin human | Injection | 018780 | December 29, 2015 | ⤷ Subscribe | 2034-05-15 |
| Eli Lilly And Company | HUMULIN R U-100 | insulin human | Injection | 018780 | August 06, 1998 | ⤷ Subscribe | 2034-05-15 |
| Eli Lilly And Company | HUMULIN R U-500 | insulin human | Injection | 018780 | March 31, 1994 | ⤷ Subscribe | 2034-05-15 |
| Eli Lilly And Company | HUMULIN R U-100 | insulin human | Injection | 018780 | May 25, 2018 | ⤷ Subscribe | 2034-05-15 |
| Novo Nordisk Inc. | NOVOLIN R | insulin human | Injection | 019938 | June 25, 1991 | ⤷ Subscribe | 2034-05-15 |
| Novo Nordisk Inc. | NOVOLIN R | insulin human | Injection | 019938 | June 01, 2018 | ⤷ Subscribe | 2034-05-15 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
